跳至主要内容
临床试验/NCT05275088
NCT05275088招募中不适用

An Exploratory Study to Evaluate the Prizvalve® System in Patients With Severe Atrioventricular Annular Calcification or Failed Prosthetic Atrioventricular Valve/ Annulus Repair

Shanghai NewMed Medical Co., Ltd.1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年3月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
1
主要终点
Technical success

研究概览

简要总结

To evaluate the safety and performance of the Prizvalve® system in patients with severe atrioventricular annular calcification or failed prosthetic atrioventricular valve/ annulus repair.

详细描述

The Prizvalve® study is a single-center, single-arm, prospective, exploratory clinical study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Technical success

时间窗: 30 days

Definition: 1. Freedom from death; 2. Successful vascular delivery and retrieval of transcatheter valve delivery system; 3. Correct position of transcatheter valve; 4. No need for any emergency surgery or re-intervention (including device-related and surgical approach-related); 5. Adequate performance of prosthesis (mean pressure gradient (MVG) \<10mmHg, valve regurgitation \<2+).

次要结局

  • All-cause mortality(30 days,1 year)
  • Device success(30 days,1 year)
  • Procedural Success(30 days,1 year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Prizvalve® Transcatheter Atrioventricular Valve... | 临床试验